… interactions. Drug interactions involving the statins may have either a pharmacodynamic or
pharmacokinetic basis, or both. As these drugs are highly extracted by the liver, displacement …

… This review will summarize the mechanism of drug–drug interactions between statins
and other drugs, using comparisons of the characteristics of statins, their physicochemical …

… pharmacokinetic properties of statins and to emphasise their clinically important drug
interactions. … lism and drug interactions of the 3-hydroxy-3-methylglutarylCoA reductase inhibitors …

… PIs to undergo drug–drug interactions [30]. … drug–drug interactions between statins and
PIs currently approved in the treatment of HIV or HCV infection. We will also discuss interactions …

… significant drug interactions and subsequent adverse drug reactions. CYP3A4 is one of the
major isoenzymes of the CYP450 group. Drug-drug interactions can occur when drugs that …

… practitioners checked the medication list for drug-drug interactions before transmitting it.
The true prevalence of drug-drug interactions may therefore be higher than found in our study. …

… drug interactions within the HMG-CoA reductase inhibitor class. These interactions can result
in markedly increased or decreased plasma concentrations of some drugs within this class. …

… in polypharmacy and the risk of drug interaction is increased with the … interaction between
statins and other drugs and to provide recommendations on how to deal with such interactions …

… Due to potential such drug interactions such as this mibefradil has been withdrawn.[8] In …
drug interactions prior to prescribing HMG-CoA reductase inhibitors, to changing HMGCoA …

… profiles of HMG-CoA reductase inhibitors and explores the specif ic drug interactions that
have … characteristics of the four HMGCoA reductase inhibitors, each agent displays a unique …